Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Active Pharmaceutical Ingredients (API) Market Size to Reach USD 105780 Million by 2027 at a CAGR of 6.6% | Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

23 Feb, 2022, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, Feb. 23, 2022 /PRNewswire/ -- The Global API Market is Segmented by Type (Synthetic APIs, Biotech APIs), by Application (Cardiovascular, CNS, Oncology, Respiratory, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes): Opportunity Analysis and Industry Forecast, 2021–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.

The global Active Pharmaceutical Ingredients Market was valued at USD 67700 Million in 2020 and it is expected to reach USD 105780 Million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.

Major Factors Driving the Growth of Active Pharmaceutical Ingredients Industry:

The active pharmaceutical ingredients market is expected to grow at a rapid rate over the forecast period, owing to an increase in the number of biosimilars and an increase in the cases of various chronic diseases.

Furthermore, factors such as increased drug R&D and biopharmaceutical uptake are expected to propel the API market forward.

Get Your Sample On API Market

TRENDS INFLUENCING THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET GROWTH:

Chronic diseases such as diabetes, coronary artery disease, chronic obstructive pulmonary disease (COPD), asthma, hepatitis, arthritis, and cancer have increased significantly in major regions around the world over the last few decades. This is due to an increase in the global geriatric population, changing lifestyles, and dietary changes as a result of rapid urbanization. APIs are a type of drug that is used to treat and prevent a variety of chronic diseases. As a result, the active pharmaceutical ingredients market is expected to grow as the number of chronic diseases rises.

The outbreak of the COVID-19 pandemic in 2020 had a positive impact on the active pharmaceutical ingredient market, as countries and major players are producing large quantities of ingredients to meet the demand for COVID 19 treatment. As a result of the COVID-19 outbreak, drug companies have redirected their models to focus on a larger group of patients.

During the forecast period, the emerging biosimilars market is expected to propel the active pharmaceutical market even further. A biosimilar is a biological product that is very similar to a reference biologic but does not differ clinically in terms of safety, purity, or potency.

The Active Ingredients market is expected to grow due to increased R&D for new drugs to address rising diseases. The API manufacturer must develop a new chemical process in order to improve industrial efficiency, which necessitates a significant technological contribution from the API manufacturer. It is therefore critical for the API manufacturer to have a cutting-edge Research & Development (R&D) facility, allowing for the transition from laboratory scale to pilot plant, and then to full industrial scale, while maintaining the characteristics required by the pharmaceutical industry for drug production and distribution. In addition, the shift in the trend toward precision medicine is expected to provide lucrative growth opportunities for API market participants.

Browse The Table Of Contents And List Of Figures At Active Pharmaceutical Ingredients Market Report

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE:

Based on type, Synthetic APIs are expected to be the most lucrative segment. This can be attributed to increased raw material availability and simplified synthesis protocols for these molecules.

Based on region, North America is expected to be the most lucrative segment. The growing incidence of preventable chronic diseases, increased government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in API manufacturing processes are all factors contributing to North America's market growth.

Get Regional Data On Active Pharmaceutical Ingredients Industry

Key Players

  • Teva
  • Mylan
  • DSM
  • Aurobindo Pharma
  • Aspen
  • Novartis
  • BASF
  • Pfizer
  • Huahai Pharmaceutical
  • Hisun Pharmaceutical
  • Sun Pharmaceutical Industries
  • Zhejiang Medicine
  • Dr. Reddy's Laboratories
  • Zhejiang NHU
  • Bayer
  • NCPC
  • AbbVie
  • Shandong Xinhua Pharmaceutical
  • Northeast Pharm
  • Harbin Pharmaceutical
  • LKPC.

Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-31E2189/Covid_19_Impact_on_Global_Active_Pharmaceutical_Ingredients_API 

Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-31E2189&lic=single-user 

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS:

-  Global Specialty Active Pharmaceutical Ingredients Market Insights, Forecast to 2028

-  Global Animal Health Active Pharmaceutical Ingredients Market Insights and Forecast to 2028

-  Global Penicillin Active Pharmaceutical Ingredients Market Outlook 2022

-  Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Insights and Forecast to 2028

-  China Heparin Active Pharmaceutical Ingredients Market Report & Forecast 2021-2027

-  Global and United States Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

-  Global and China Generic Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

-  Global and China Diclofenac Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

-  Global and Japan Aspirin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

-  Global and China Antipyretic Analgesic Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

-  Global and Japan Sterile Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

Click here to see related reports on Pharmaceutical Ingredients Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com 
Twitter - https://twitter.com/valuatesreports 
LinkedIn - https://in.linkedin.com/company/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg  

Modal title

Also from this source

Coolant Distribution Units for Data Centers Market to Soar as AI and HPC Drive Cooling Demand | Valuates Reports

Coolant Distribution Units for Data Centers Market to Soar as AI and HPC Drive Cooling Demand | Valuates Reports

The global market for Coolant Distribution Units (CDU) for Data Center was valued at USD 971 Million in the year 2024 and is projected to reach a...

Customized Premixes Market to Reach USD 1.47 Billion by 2030, Driven by Demand for Personalized Nutrition | Valuates Reports

Customized Premixes Market to Reach USD 1.47 Billion by 2030, Driven by Demand for Personalized Nutrition | Valuates Reports

The Global Customized Premixes Market was valued at USD 1186.1 Million in 2023 and is anticipated to reach USD 1474.2 Million by 2030, witnessing a...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.